146 Views
Sunday Poster Session
Category: Colorectal Cancer Prevention
Girish Putcha, MD, PhD
Freenome
South San Francisco, CA, United States
CRC Incidence Reduction | CRC Mortality Reduction | ||||
Performance Metric (range) | Change in #COL | Change in CRC IR | Burden-to-Benefit | Change in CRC MR | Burden-to-Benefit |
All adenoma size groups | 287.3 | 5.7% | 50.0 | 3.8% | 76.0 |
1-5mm Sensitivity (10% to 20%) | 238.8 | 2.6% | 93.3 | 1.8% | 133.1 |
6-9mm Sensitivity (15% to 25%) | 34.5 | 2.0% | 17.0 | 1.3% | 26.9 |
≥10mm Sensitivity (25% to 35%) | 12.3 | 1.0% | 12.6 | 0.6% | 21.5 |
CRC Sensitivity (85% to 95%) | < < 0.1 | < -0.1% | -0.4 | 0.1% | < 0.1 |
Specificity (85% to 95%) | -623.1 | 0.8% | -764.8 | 0.8% | -779.9 |